相关视频 - | JoVE Visualize

Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

Search research articles

相关实验视频

Ole Skouvig Pedersen¹, Frauke Rudolf², Isik Somuncu Johansen³

¹Lungesygdomme, Aarhus Universitetshospital.

Ugeskrift for laeger

|March 6, 2024

概括

耐药结核病 (DR-TB) 是一个日益增长的全球健康威胁. 虽然新的治疗方法显示出希望,但如新出现的耐药性等持续挑战需要继续开发结核病的药物.

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Epidemiology and outcomes of urosepsis among admitted patients with urinary tract infections in Danish Emergency Departments: a retrospective cohort study.

Infectious diseases (London, England)·2026

Same author

Increased sensitivity of the updated FluoroType MTBDR V2 with addition of IS<i>6110</i> analysis.

Journal of clinical microbiology·2026

Same author

AdMiRE study: Development and validation of a WHO-aligned tool to assess healthcare access and antibiotic use among migrant populations in Europe-a multicountry Delphi and psychometric study on behalf of ESGITM group.

CMI communications·2026

Same author

Interferon-gamma release assay screening before solid organ transplantation in a low-incidence country: a prospective single-center cohort study.

Scientific reports·2026

Same author

Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPD.

Journal of clinical medicine·2026

Same author

Socioeconomic disparities and mortality among acute patients with sepsis: a retrospective Danish cohort study.

BMJ open·2026

科学领域:

公共卫生公共卫生
传染性疾病传染性疾病
微生物学微生物学

背景情况:

耐药结核病 (DR-TB) 是一个显著且日益严重的全球卫生挑战.
现有的治疗方案面临着局限性和不断变化的耐药性模式.

结论:

尽管取得了进展,但DR-TB的威胁仍然存在,原因是耐药性不断发展.
药物发现的持续创新对于克服最耐药的结核病形式至关重要.
结合新药和流行病学监测的多方面的方法至关重要.